In this study, we applied novel therapeutic approaches to suppress growth of PCa by using tamoxifen alone or in combination with PIP5K1α inhibitor ISA‐2011B to targeting estrogen/ERα and PIP5K1α/Akt pathways in cell line and in mouse models. This evidence concerns the gene AKT1 and posterior cortical atrophy.